International Drug Policy Consortium (IDPC)
Description: The International Drug Policy Consortium (IDPC) is a global network of around 200 NGOs that focus on issues related to drug production, trafficking and use.
IDPC promotes objective and open debate on the effectiveness, direction and content of drug policies at the national and international level, and supports evidence-based policies that are effective at reducing drug-related harm. Our advocacy positions are based on five core policy principles: https://idpc.net/policy-principles.
We produce briefing papers, disseminate key resources on drug policy, build the advocacy capacity of our members and partners, and offer expert advice to policy makers and officials around the world. Our global membership has expertise and experience on the wide spectrum of drug policy issues.
Address: 61 MANSELL STREET E1 8AN London United Kingdom
Areas of interest:
Priorities and Evidence
Drug policies should be developed through a structured and objective assessment of priorities and evidence which includes:
Closing doors: The exclusion of civil society at the ‘topical meetings’ of the UN Commission on Narcotic DrugsIDPC explains how civil society has been excluded from the newly-created ‘topical meetings' on the WHO cannabis re-scheduling recommendations, and why this departs from recent progress on openness and civil society participation.
IDPC calls on African States to take urgent action to ensure the safety and health of prison staff and people deprived of liberty.
Imprisoned at home: Women under house arrest in Latin America
This report emphasizes the need for authorities to consider combining home detention with educational or job-training programs, evidence-based drug treatment and other forms of community support.
The #warondrugs is built on racism. It's time to decolonise drug policies.
While repressive drug policies have weaponised the state against communities of colour, it is sadly crucial to remember it was in part designed to do just that.
Read Ann Fordham's blog here: https://idpc.net/blog/2020/06/the-war-on-drugs-is-built-on-racism-it-s-time-to-decolonise-drug-policies
#HarmReduction needs defending, not defunding! The Netherlands' retreat from promoting harm reduction worldwide, amidst a funding crisis, will cost lives.
If you agree #HarmReductionSavesLives, please sign and share here: https://forms.gle/VQESnhuGkY85Vk7AA
IDPC offers recommendations to the new UNODC Director related to a range of key concerns, including on UN system-wide coherence, human rights and health.
Read more here: https://idpc.net/publications/2020/02/recommendations-for-the-new-unodc-executive-director-opportunities-and-challenges-in-global-drug-policy
Prisons and detention facilities are a high-risk environment for the spread of #COVID19, especially where they are overcrowded, cannot maintain adequate standards of sanitation and hygiene, and are limited in their capacity to ensure access to medical treatment.
In several countries around the world, the heightened risks of #COVID19 infection in prisons, combined with new restrictions on visits and communication with people outside prison, has intensified anxiety and tensions amongst people held within them, in some cases resulting in riots, escapes and violence.
Ensuring the safety and health of both prison staff, and people deprived of liberty, requires urgent action to reduce the risks and consequences of widespread #COVID19 infection. This advocacy note makes recommendations for reducing such risks and consequences, including by early release from, and suspension of arrests and admission into, prions, jails and other detention settings including drug rehabilitation centres in Southeast Asia.
Ann Fordham (IDPC Executive Director) discusses key #CND63 highlights.
The #COVID19 pandemic represents a global challenge whose ramifications are serious and difficult to accurately predict. Communities targeted by the "war on drugs", living in situations of vulnerability, experiencing exclusion, stigmatisation and criminalisation, will bear a differentiated and disproportionate burden of the negative consequences associated with the pandemic. IDPC has created a thematic list of information and guidance resources that we will continue to update in the coming weeks as a means to promote resilience and solidarity.
This Guide brings together global evidence, best practice and experiences to provide expert analysis across the spectrum of drug policy.